{"id": "article-28852_0", "title": "Selective Serotonin Reuptake Inhibitors -- Continuing Education Activity", "content": "Selective serotonin reuptake inhibitors (SSRIs) are a class of medications most commonly prescribed to treat depression. They are often used as first-line pharmacotherapy for depression and numerous other psychiatric disorders due to their safety, efficacy, and tolerability. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the care of patients with depression and other psychiatric disorders for which SSRIs are indicated.", "contents": "Selective Serotonin Reuptake Inhibitors -- Continuing Education Activity. Selective serotonin reuptake inhibitors (SSRIs) are a class of medications most commonly prescribed to treat depression. They are often used as first-line pharmacotherapy for depression and numerous other psychiatric disorders due to their safety, efficacy, and tolerability. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the care of patients with depression and other psychiatric disorders for which SSRIs are indicated."}
{"id": "article-28852_1", "title": "Selective Serotonin Reuptake Inhibitors -- Continuing Education Activity", "content": "Objectives: Identify the indications for SSRIs. Describe the most common adverse effects of SSRIs. Review the mechanism of action of SSRIs. Explain the importance of collaboration and communication amongst the interprofessional team members to improve outcomes for patients receiving SSRIs. Access free multiple choice questions on this topic.", "contents": "Selective Serotonin Reuptake Inhibitors -- Continuing Education Activity. Objectives: Identify the indications for SSRIs. Describe the most common adverse effects of SSRIs. Review the mechanism of action of SSRIs. Explain the importance of collaboration and communication amongst the interprofessional team members to improve outcomes for patients receiving SSRIs. Access free multiple choice questions on this topic."}
{"id": "article-28852_2", "title": "Selective Serotonin Reuptake Inhibitors -- Indications", "content": "Selective serotonin reuptake inhibitors (SSRIs) are a class of medications most commonly prescribed to treat depression. They are often used as first-line pharmacotherapy for depression and numerous other psychiatric disorders due to their safety, efficacy, and tolerability. They are approved for use in both adult and pediatric patients. [1] The current SSRIs in use in the United States are: Fluoxetine Sertraline Paroxetine Fluvoxamine Citalopram Escitalopram Vilazodone SSRIs currently have FDA labeled indications\u00a0to treat the following conditions: Major depressive disorder Generalized anxiety disorder Bulimia nervosa Bipolar depression [2] Obsessive-compulsive disorder Panic disorder Premenstrual dysphoric disorder Treatment-resistant depression Post-traumatic stress disorder Social anxiety disorder", "contents": "Selective Serotonin Reuptake Inhibitors -- Indications. Selective serotonin reuptake inhibitors (SSRIs) are a class of medications most commonly prescribed to treat depression. They are often used as first-line pharmacotherapy for depression and numerous other psychiatric disorders due to their safety, efficacy, and tolerability. They are approved for use in both adult and pediatric patients. [1] The current SSRIs in use in the United States are: Fluoxetine Sertraline Paroxetine Fluvoxamine Citalopram Escitalopram Vilazodone SSRIs currently have FDA labeled indications\u00a0to treat the following conditions: Major depressive disorder Generalized anxiety disorder Bulimia nervosa Bipolar depression [2] Obsessive-compulsive disorder Panic disorder Premenstrual dysphoric disorder Treatment-resistant depression Post-traumatic stress disorder Social anxiety disorder"}
{"id": "article-28852_3", "title": "Selective Serotonin Reuptake Inhibitors -- Indications", "content": "Other off-label uses include but are not limited to: Binge eating disorder, Body dysmorphic disorder, fibromyalgia, premature ejaculation, paraphilias, autism, Raynaud phenomenon, and vasomotor symptoms associated with menopause. [3]", "contents": "Selective Serotonin Reuptake Inhibitors -- Indications. Other off-label uses include but are not limited to: Binge eating disorder, Body dysmorphic disorder, fibromyalgia, premature ejaculation, paraphilias, autism, Raynaud phenomenon, and vasomotor symptoms associated with menopause. [3]"}
{"id": "article-28852_4", "title": "Selective Serotonin Reuptake Inhibitors -- Mechanism of Action", "content": "The therapeutic actions of SSRIs\u00a0have their basis on increasing deficient serotonin that researchers postulate as the cause of depression in the monoamine hypothesis. As the name suggests, SSRIs exert action by inhibiting the reuptake of serotonin, thereby increasing serotonin activity. Unlike other classes of antidepressants, SSRIs\u00a0have little effect on other neurotransmitters, such as dopamine or norepinephrine. SSRIs also have relatively fewer side effects than TCAs and MAOIs due to fewer effects on adrenergic, cholinergic, and histaminergic receptors.", "contents": "Selective Serotonin Reuptake Inhibitors -- Mechanism of Action. The therapeutic actions of SSRIs\u00a0have their basis on increasing deficient serotonin that researchers postulate as the cause of depression in the monoamine hypothesis. As the name suggests, SSRIs exert action by inhibiting the reuptake of serotonin, thereby increasing serotonin activity. Unlike other classes of antidepressants, SSRIs\u00a0have little effect on other neurotransmitters, such as dopamine or norepinephrine. SSRIs also have relatively fewer side effects than TCAs and MAOIs due to fewer effects on adrenergic, cholinergic, and histaminergic receptors."}
{"id": "article-28852_5", "title": "Selective Serotonin Reuptake Inhibitors -- Mechanism of Action", "content": "SSRIs inhibit the serotonin transporter (SERT) at the presynaptic axon terminal. By\u00a0inhibiting\u00a0SERT, an increased amount of serotonin (5-hydroxytryptamine or 5HT) remains in the synaptic cleft and can stimulate postsynaptic receptors for a more extended period. [4] [5] [6]", "contents": "Selective Serotonin Reuptake Inhibitors -- Mechanism of Action. SSRIs inhibit the serotonin transporter (SERT) at the presynaptic axon terminal. By\u00a0inhibiting\u00a0SERT, an increased amount of serotonin (5-hydroxytryptamine or 5HT) remains in the synaptic cleft and can stimulate postsynaptic receptors for a more extended period. [4] [5] [6]"}
{"id": "article-28852_6", "title": "Selective Serotonin Reuptake Inhibitors -- Administration", "content": "SSRIs are only available orally and come in multiple forms, including tablets, capsules, or liquid suspension/solution. There are currently no parenteral (IV, IM, SubQ), rectal, or other forms of SSRIs. SSRI administration is typically once-daily medication in the morning or nighttime.\u00a0Except for vilazodone, SSRIs\u00a0may be taken without regard to food. Vilazodone should be administered with food. [6]", "contents": "Selective Serotonin Reuptake Inhibitors -- Administration. SSRIs are only available orally and come in multiple forms, including tablets, capsules, or liquid suspension/solution. There are currently no parenteral (IV, IM, SubQ), rectal, or other forms of SSRIs. SSRI administration is typically once-daily medication in the morning or nighttime.\u00a0Except for vilazodone, SSRIs\u00a0may be taken without regard to food. Vilazodone should be administered with food. [6]"}
{"id": "article-28852_7", "title": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects", "content": "The popularity and widespread use of SSRIs is due in part to their relatively fewer side effects than prior commonly used antidepressants such as TCAs and MAOIs. SSRIs have little or no effect on dopamine, norepinephrine, histamine, or acetylcholine (except for paroxetine). This characteristic leads to fewer complaints of side effects such as xerostomia, sedation, constipation, urinary retention, and cognitive impairments. [7] [8]", "contents": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects. The popularity and widespread use of SSRIs is due in part to their relatively fewer side effects than prior commonly used antidepressants such as TCAs and MAOIs. SSRIs have little or no effect on dopamine, norepinephrine, histamine, or acetylcholine (except for paroxetine). This characteristic leads to fewer complaints of side effects such as xerostomia, sedation, constipation, urinary retention, and cognitive impairments. [7] [8]"}
{"id": "article-28852_8", "title": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects", "content": "Increased tolerability compared to other classes of medications make SSRIs first-line options for their indicated uses. Although relatively safer due to their selectiveness for serotonin, SSRIs are not without risks.", "contents": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects. Increased tolerability compared to other classes of medications make SSRIs first-line options for their indicated uses. Although relatively safer due to their selectiveness for serotonin, SSRIs are not without risks."}
{"id": "article-28852_9", "title": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects", "content": "In 2004, the FDA issued a black box warning for SSRIs and other antidepressant medications due to a possible increased risk of suicidality among pediatric and young adult (up to age 25) populations. The risk and benefits of initiating SSRI therapy on acutely suicidal patients must be weighed, keeping in mind that depression itself is a large risk factor for suicidality and requires treatment. Common side effects from SSRIs include sexual dysfunction, sleep disturbances, weight changes, anxiety, dizziness, xerostomia, headache, and gastrointestinal distress. [9] [10]", "contents": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects. In 2004, the FDA issued a black box warning for SSRIs and other antidepressant medications due to a possible increased risk of suicidality among pediatric and young adult (up to age 25) populations. The risk and benefits of initiating SSRI therapy on acutely suicidal patients must be weighed, keeping in mind that depression itself is a large risk factor for suicidality and requires treatment. Common side effects from SSRIs include sexual dysfunction, sleep disturbances, weight changes, anxiety, dizziness, xerostomia, headache, and gastrointestinal distress. [9] [10]"}
{"id": "article-28852_10", "title": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects", "content": "SSRIs also have the potential to prolong the\u00a0QT interval, which can lead to fatal arrhythmia, torsade de pointes. Citalopram has correlations with a longer QT duration than the other medications in this class. [11] [12] Coagulopathy also correlates with SSRI use. [13] Although infrequent, as with all medications that increase serotonin activity, it is important to be aware of the risk of serotonin syndrome, particularly when prescribing multiple medications that may have serotonergic effects.", "contents": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects. SSRIs also have the potential to prolong the\u00a0QT interval, which can lead to fatal arrhythmia, torsade de pointes. Citalopram has correlations with a longer QT duration than the other medications in this class. [11] [12] Coagulopathy also correlates with SSRI use. [13] Although infrequent, as with all medications that increase serotonin activity, it is important to be aware of the risk of serotonin syndrome, particularly when prescribing multiple medications that may have serotonergic effects."}
{"id": "article-28852_11", "title": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects", "content": "SSRIs\u00a0are metabolized by and have effects on the\u00a0cytochrome P450 system. Fluoxetine, paroxetine, sertraline, citalopram, and\u00a0escitalopram are inhibitors of CYP2D6. Fluoxetine and fluvoxamine are inhibitors of CYP2C19. Fluvoxamine is an inhibitor of CYP1A2. [6]", "contents": "Selective Serotonin Reuptake Inhibitors -- Adverse Effects. SSRIs\u00a0are metabolized by and have effects on the\u00a0cytochrome P450 system. Fluoxetine, paroxetine, sertraline, citalopram, and\u00a0escitalopram are inhibitors of CYP2D6. Fluoxetine and fluvoxamine are inhibitors of CYP2C19. Fluvoxamine is an inhibitor of CYP1A2. [6]"}
{"id": "article-28852_12", "title": "Selective Serotonin Reuptake Inhibitors -- Contraindications", "content": "SSRIs are contraindicated with the concurrent use of MAOIs, linezolid, and other medications that increase serotonin levels and could put patients at risk for life-threatening serotonin syndrome.", "contents": "Selective Serotonin Reuptake Inhibitors -- Contraindications. SSRIs are contraindicated with the concurrent use of MAOIs, linezolid, and other medications that increase serotonin levels and could put patients at risk for life-threatening serotonin syndrome."}
{"id": "article-28852_13", "title": "Selective Serotonin Reuptake Inhibitors -- Contraindications", "content": "Paroxetine is contraindicated in pregnancy and is classified as category D/X due to its teratogenic effects in causing cardiovascular defects, specifically cardiac malformations if prescribed in the first trimester. [14]", "contents": "Selective Serotonin Reuptake Inhibitors -- Contraindications. Paroxetine is contraindicated in pregnancy and is classified as category D/X due to its teratogenic effects in causing cardiovascular defects, specifically cardiac malformations if prescribed in the first trimester. [14]"}
{"id": "article-28852_14", "title": "Selective Serotonin Reuptake Inhibitors -- Monitoring", "content": "The effect of SSRIs may take up to 6 weeks before the patients feel the effects of treatment. [15] If patients tolerate the current dose well, the clinician can consider an increase in dosage after several weeks. All patients under the age of 25 should be continually assessed for suicidal ideation and other unusual behaviors, as highlighted in the FDA black box warning for all SSRI medications. For patients with cardiac risk factors, an EKG may be an option to monitor for QT prolongation and arrhythmias. Weight should be regularly measured and tracked to determine any adverse metabolic changes, and vital signs should also be regularly measured to monitor for adverse changes. Anxiety, insomnia, and sexual dysfunction (delayed ejaculation, decreased sexual desire, and anorgasmia) require regular assessment.", "contents": "Selective Serotonin Reuptake Inhibitors -- Monitoring. The effect of SSRIs may take up to 6 weeks before the patients feel the effects of treatment. [15] If patients tolerate the current dose well, the clinician can consider an increase in dosage after several weeks. All patients under the age of 25 should be continually assessed for suicidal ideation and other unusual behaviors, as highlighted in the FDA black box warning for all SSRI medications. For patients with cardiac risk factors, an EKG may be an option to monitor for QT prolongation and arrhythmias. Weight should be regularly measured and tracked to determine any adverse metabolic changes, and vital signs should also be regularly measured to monitor for adverse changes. Anxiety, insomnia, and sexual dysfunction (delayed ejaculation, decreased sexual desire, and anorgasmia) require regular assessment."}
{"id": "article-28852_15", "title": "Selective Serotonin Reuptake Inhibitors -- Toxicity", "content": "SSRI overdose is relatively infrequent due to their increased safety profile and tolerability compared to other classes of antidepressants.\u00a0SSRI overdoses are rarely fatal and usually do not have serious consequences.\u00a0Out of all the SSRIs, citalopram and escitalopram are more likely to cause overdose due to differences in their structures. Citalopram and escitalopram have an increased risk of\u00a0cardiotoxicity due to QT prolongation, which can progress to serious arrhythmias such as Torsades.", "contents": "Selective Serotonin Reuptake Inhibitors -- Toxicity. SSRI overdose is relatively infrequent due to their increased safety profile and tolerability compared to other classes of antidepressants.\u00a0SSRI overdoses are rarely fatal and usually do not have serious consequences.\u00a0Out of all the SSRIs, citalopram and escitalopram are more likely to cause overdose due to differences in their structures. Citalopram and escitalopram have an increased risk of\u00a0cardiotoxicity due to QT prolongation, which can progress to serious arrhythmias such as Torsades."}
{"id": "article-28852_16", "title": "Selective Serotonin Reuptake Inhibitors -- Toxicity", "content": "Serotonin syndrome is a life-threatening consequence of increased serotonergic activity. It can result from overdosing on SSRIs or from combining multiple medications that increase serotonin levels. Serotonin syndrome is characterized by mental status changes, autonomic dysfunction, and dystonias. Findings may include agitation, tachycardia, hypertension, hyperthermia,\u00a0hyperreflexia, tremor, nausea, vomiting, and clonus. [16] Serotonin syndrome may present similarly to neuroleptic malignant syndrome and malignant hyperthermia. This is\u00a0especially important to keep in mind since commonly prescribed psychiatric medications can cause both serotonin syndrome and neuroleptic malignant syndrome. In general, serotonin syndrome is distinguishable by taking a thorough history. Serotonin syndrome also has a rapid onset and resolution. There is no definitive treatment for serotonin syndrome aside from discontinuing the offending agent, supportive measures, and benzodiazepines for agitation. Cyproheptadine has shown some success in several small studies and case reports for patients who do not respond to initial treatment.", "contents": "Selective Serotonin Reuptake Inhibitors -- Toxicity. Serotonin syndrome is a life-threatening consequence of increased serotonergic activity. It can result from overdosing on SSRIs or from combining multiple medications that increase serotonin levels. Serotonin syndrome is characterized by mental status changes, autonomic dysfunction, and dystonias. Findings may include agitation, tachycardia, hypertension, hyperthermia,\u00a0hyperreflexia, tremor, nausea, vomiting, and clonus. [16] Serotonin syndrome may present similarly to neuroleptic malignant syndrome and malignant hyperthermia. This is\u00a0especially important to keep in mind since commonly prescribed psychiatric medications can cause both serotonin syndrome and neuroleptic malignant syndrome. In general, serotonin syndrome is distinguishable by taking a thorough history. Serotonin syndrome also has a rapid onset and resolution. There is no definitive treatment for serotonin syndrome aside from discontinuing the offending agent, supportive measures, and benzodiazepines for agitation. Cyproheptadine has shown some success in several small studies and case reports for patients who do not respond to initial treatment."}
{"id": "article-28852_17", "title": "Selective Serotonin Reuptake Inhibitors -- Enhancing Healthcare Team Outcomes", "content": "SSRIs are currently some of the most commonly prescribed medications. They are used to treat numerous conditions and may be used in many settings, not just in primary care or psychiatry.\u00a0Patients may be on these medications for the long term. Therefore, it is essential to have accurate medication reconciliation by the entire interprofessional team, including clinicians, pharmacists, nursing staff, and other health professionals. This interprofessional approach to SSRI therapy will lead to better patient outcomes with fewer adverse events. [Level 5]", "contents": "Selective Serotonin Reuptake Inhibitors -- Enhancing Healthcare Team Outcomes. SSRIs are currently some of the most commonly prescribed medications. They are used to treat numerous conditions and may be used in many settings, not just in primary care or psychiatry.\u00a0Patients may be on these medications for the long term. Therefore, it is essential to have accurate medication reconciliation by the entire interprofessional team, including clinicians, pharmacists, nursing staff, and other health professionals. This interprofessional approach to SSRI therapy will lead to better patient outcomes with fewer adverse events. [Level 5]"}
{"id": "article-28852_18", "title": "Selective Serotonin Reuptake Inhibitors -- Enhancing Healthcare Team Outcomes", "content": "Serotonin syndrome is important to keep in mind due to the widespread use of SSRIs. If suspected by a triage nurse in an emergency setting, it is important that the emergency medicine physician immediately begin supportive treatment.\u00a0Coordinating with the intensivist and ICU nursing staff may also be required as\u00a0treatment\u00a0may require immediate sedation and intubation. A neurologist may also be important for ongoing care. Although there is no definitive treatment for serotonin syndrome, researchers have trialed cyproheptadine with some success in small studies and case reports. [17] [18] [19] [20] [Level 4]", "contents": "Selective Serotonin Reuptake Inhibitors -- Enhancing Healthcare Team Outcomes. Serotonin syndrome is important to keep in mind due to the widespread use of SSRIs. If suspected by a triage nurse in an emergency setting, it is important that the emergency medicine physician immediately begin supportive treatment.\u00a0Coordinating with the intensivist and ICU nursing staff may also be required as\u00a0treatment\u00a0may require immediate sedation and intubation. A neurologist may also be important for ongoing care. Although there is no definitive treatment for serotonin syndrome, researchers have trialed cyproheptadine with some success in small studies and case reports. [17] [18] [19] [20] [Level 4]"}
{"id": "article-28852_19", "title": "Selective Serotonin Reuptake Inhibitors -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Selective Serotonin Reuptake Inhibitors -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}